TABLE 3.

Differential gene analysis of top genes in those with or without infection

	CLAD no infection versus non-CLAD		CLAD infection versus CLAD no infection
	Fold change	FDR P-value	Log fold change	FDR P-value
IDO1	30.21	<1.00E−13	1.51	1.00
ADAMDEC1	6.02	1.79E−6	1.97	1.00
TNFRSF6B	243.46	<1.00E−13	1.31	1.00
SLC5A5	15.22	6.50E−8	2.74	1.00
MMP9	6.35	4.16E−5	1.73	1.00
SERPINA3	8.88	1.05E−7	2.59	1.00
IGKC	19.41	4.23E−9	−1.64	1.00
IGHA1	16.70	1.48E−9	−1.44	1.00
BCL2L15	3.59	6.50E−8	1.03	1.00
MUC13	5.15	2.24E−7	1.06	1.00
C15orf48	5.41	9.00E−8	2.22	1.00
FCAR	4.13	6.32E−3	4.06	1.00
KRT6B	4.89	2.44E−7	1.00	1.00
MIA	3.51	7.69E−7	1.53	1.00
IGHM	17.40	1.00E−7	−1.44	1.00
CXCL9	17.99	1.74E−10	−1.38	1.00
CXCL13	26.05	5.27E−7	1.08	1.00
CXCR4	2.74	5.67E−3	2.61	1.00
SAA2-SAA4	6.92	1.00E−7	1.89	1.00
CLC	6.01	5.44E−3	2.28	1.00
SAA2	5.97	1.42E−7	1.54	1.00
ATP10B	3.79	8.91E−6	1.42	1.00
CXCL8	5.78	3.63E−5	1.03	1.00
TCIM	4.78	2.16E−6	1.15	1.00
PTPRH	6.60	2.82E−6	1.02	1.00